Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of ...

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

Alterity Therapeutics has its roots in developing drugs for neurodegeneration with its latest focus on Parkinson’s disease ...

Parkinson’s disease and Alzheimer’s disease ... SGLT2 inhibitors had been introduced as a new treatment for diabetes. These drugs not only lower blood sugar but also increase urinary glucose ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...